Smith Mark Alan 4
4 · VistaGen Therapeutics, Inc. · Filed Jul 15, 2022
Insider Transaction Report
Form 4
Smith Mark Alan
CHIEF MEDICAL OFFICER
Transactions
- Award
Common Stock
2022-06-30$0.75/sh+5,000$3,740→ 19,915 total
Footnotes (1)
- [F1]Shares purchased under the VistaGen Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c)